Evidence map›Paper›PMID 24509509›Full record

ArticleNature immunology2014

Stage-specific control of early B cell development by the transcription factor Ikaros.

Tanja A Schwickert, Hiromi Tagoh, Sinan Gültekin, Aleksandar Dakic, Elin Axelsson, Martina Minnich, Anja Ebert, Barbara Werner, Mareike Roth, Luisa Cimmino and 4 more

Open access · greenAbstract read
In one paragraph

Article in Nature immunology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 137 papers.

0numbers the graph read from it
0cells of the map it votes in
137citing papers in PubMed
29.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

137 citing papers in PubMed, 213 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review

77 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 3 institutions in 2 countries.

Tanja A Schwickert1] Research Institute of Molecular Pathology, Vienna Biocenter, Vienna, Austria. [2].
Hiromi Tagoh1] Research Institute of Molecular Pathology, Vienna Biocenter, Vienna, Austria. [2].
Sinan GültekinResearch Institute of Molecular Pathology, Vienna Biocenter, Vienna, Austria.
Aleksandar Dakic1] Research Institute of Molecular Pathology, Vienna Biocenter, Vienna, Austria. [2].
Elin AxelssonResearch Institute of Molecular Pathology, Vienna Biocenter, Vienna, Austria.
Martina MinnichResearch Institute of Molecular Pathology, Vienna Biocenter, Vienna, Austria.
Anja EbertResearch Institute of Molecular Pathology, Vienna Biocenter, Vienna, Austria.
Barbara WernerResearch Institute of Molecular Pathology, Vienna Biocenter, Vienna, Austria.
Mareike RothResearch Institute of Molecular Pathology, Vienna Biocenter, Vienna, Austria.
Luisa CimminoThe Walter and Eliza Hall Institute of Medical Research, Parkville, Australia.
Ross A DickinsThe Walter and Eliza Hall Institute of Medical Research, Parkville, Australia.
Johannes ZuberResearch Institute of Molecular Pathology, Vienna Biocenter, Vienna, Austria.
Markus JaritzResearch Institute of Molecular Pathology, Vienna Biocenter, Vienna, Austria.
Meinrad BusslingerResearch Institute of Molecular Pathology, Vienna Biocenter, Vienna, Austria.
Vienna Biocenter · ATResearch Institute of Molecular Pathology · ATWalter and Eliza Hall Institute of Medical Research · AU

Funding

European Research Council 291740
6 · The paper itself

Abstract

The transcription factor Ikaros is an essential regulator of lymphopoiesis. Here we studied its B cell-specific function by conditional inactivation of the gene encoding Ikaros (Ikzf1) in pro-B cells. B cell development was arrested at an aberrant 'pro-B cell' stage characterized by increased cell adhesion and loss of signaling via the pre-B cell signaling complex (pre-BCR). Ikaros activated genes encoding signal transducers of the pre-BCR and repressed genes involved in the downregulation of pre-BCR signaling and upregulation of the integrin signaling pathway. Unexpectedly, derepression of expression of the transcription factor Aiolos did not compensate for the loss of Ikaros in pro-B cells. Ikaros induced or suppressed active chromatin at regulatory elements of activated or repressed target genes. Notably, binding of Ikaros and expression of its target genes were dynamically regulated at distinct stages of early B lymphopoiesis.

Indexed as

AnimalsB-LymphocytesCell DifferentiationChromatin ImmunoprecipitationFlow CytometryGene Expression RegulationGene Knockdown TechniquesIkaros Transcription FactorLymphopoiesisMiceMice, Inbred C57BLMice, TransgenicPrecursor Cells, B-LymphoidIkaros Transcription FactorZfpn1a1 protein, mouse

Identifiers

PMID24509509
PMCPMC5790181
OpenAlexW1985772010

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.